Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Please send your application by email, with the subject "PhD Application - HIV p24", no later than October 1, 2025, to: Dr. Enrico Richter Institute of Virology University Hospital Bonn ✉ Email
-
a PhD in Chemistry, Physics or Materials Science with a proven research track record and solid background enabling the study of completely new problems. The post is available until 30 September 2026
-
(Level A) $81,293 to $109,307 per annum plus an employer contribution of 17% superannuation applies. Full time, fixed term position for 12 months Together with the University of Adelaide’s, Adelaide Centre for Epigenetics (ACE), the South Australian immunoGENomics Cancer Institute (SAiGENCI) is...
-
Prof. dr. Laurens Liesenborghs, tel.: +32 16 32 70 42, mail: laurens.liesenborghs@kuleuven.be. You can apply for this job no later than 25/08/2025 via the online application tool
-
public transport connections (U1/U4 Karlsplatz) Your Application: We invite highly qualified and motivated students interested in this exciting research field to send us their detailed application
-
physics, chemistry, or related areas. Please send your application as a single pdf-file including a letter of motivation, a CV, certificates of your university degree (including grades), a transcript of
-
Social Code IX (SGB IX) will receive priority for employment. Please submit your detailed application with the usual documents by August 15, 2025 (stamped arrival date of the university central mail service
-
. Peter Dedecker, mail: peter.dedecker@kuleuven.be or Prof. dr. Shehab Ismail Mohamed, mail: shehab.ismail.mohamed@kuleuven.be. You can apply for this job no later than 23/06/2025 via the online application
-
-mature.org and send it together with a cover letter, a curriculum vitae, a copy of all university degrees and other certificates in a single pdf-file to gerd.bacher@uni-due.de . Please mention in your
-
based on post-genomic technologies and focuses on societally important diseases, such as immune disorders and infections, cancer, metabolic disorders, and aging. The goal of CeMM is to pioneer the science